Synergistic effect of urotensin II with serotonin on vascular smooth muscle cell proliferation

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Hypertension

• Publication date

  2001-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0735-1097(03)82433-6PMID 11725163
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Monocyte chemotactic protein 1 amplifies serotonin-induced vascular smooth muscle cell proliferation.

  2002cited by this paper
• Lipid peroxidation product 4-hydroxy-2-nonenal acts synergistically with serotonin in inducing vascular smooth muscle cell proliferation.

  2001cited by this paper
• Angiotensin II and serotonin potentiate endothelin-1-induced vascular smooth muscle cell proliferation

  2001cited by this paper
• Lysophosphatidylcholine and Reactive Oxygen Species Mediate the Synergistic Effect of Mildly Oxidized LDL With Serotonin on Vascular Smooth Muscle Cell Proliferation

  2001cited by this paper
• Synergistic Effect of Urotensin II With Mildly Oxidized LDL on DNA Synthesis in Vascular Smooth Muscle Cells

  2001cited by this paper
• High Plasma Serotonin Levels in Primary Pulmonary Hypertension: Effect of Long-Term Epoprostenol (Prostacyclin) Therapy

  2000cited by this paper
• Human urotensin II mediates vasoconstriction via an increase in inositol phosphates.

  2000cited by this paper
• Differential vasoconstrictor activity of human urotensin‐II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey

  2000cited by this paper
• Contractile responses to human urotensin‐II in rat and human pulmonary arteries: effect of endothelial factors and chronic hypoxia in the rat

  2000cited by this paper
• [Effect of urotensin II on the airway smooth muscle cell proliferation and its mechanism].

  2000cited by this paper
• Mechanisms of 5-hydroxytryptamine(2A) receptor activation of the mitogen-activated protein kinase pathway in vascular smooth muscle.

  1999cited by this paper
• Serotonin is associated with coronary artery disease and cardiac events.

  1999cited by this paper
• Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

  1999cited by this paper
• Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension

  1999cited by this paper
• Synergy between thrombin and serotonin in inducing vascular smooth muscle cell proliferation.

  1999cited by this paper
• Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord.

  1998cited by this paper
• Effect of serotonin, thromboxane A2, and specific receptor antagonists on vascular smooth muscle cell proliferation.

  1997cited by this paper
• Augmented Vasoconstrictor Responses to Serotonin Precede Development of Atherosclerosis in Aorta of WHHL Rabbit

  1989cited by this paper
• Functional receptors for fish neuropeptide urotensin II in major rat arteries.

  1988cited by this paper
• Complex effects of Gillichthys urotensin II on rat aortic strips

  1987cited by this paper
• Cardiovascular effects of urotensin II in anesthetized and pithed rats.

  1986cited by this paper
• Neuropeptide-induced contraction and relaxation of the mouse anococcygeus muscle.

  1984cited by this paper
• Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes.

  1980cited by this paper
• The Pathology of Hypertensive Pulmonary Vascular Disease: A Description of Six Grades of Structural Changes in the Pulmonary Arteries with Special Reference to Congenital Cardiac Septal Defects

  1958cited by this paper

• Insulin use promotes pro-inflammatory changes in the transcriptome of atherosclerotic plaques in patients with diabetes mellitus

  2025cites this paper
• Neuropeptides as Potential Biomarkers in Vascular Dementia.

  2024cites this paper
• Roles of the kisspeptin/GPR54 system in pathomechanisms of atherosclerosis.

  2020cites this paper
• Urotensin II, urotensin-related peptide, and their receptor in aortic valve stenosis.

  2019cites this paper
• Should we abandon the term 〝lone atrial fibrillation〞?

  2019cites this paper
• Effects of Urotensin II on Excitation-Contraction Coupling in Hypertrophic Heart Failure

  2018cites this paper
• Synthèse en phase solide de pyrrolo[3,2-e][1,4]diazépin-2-ones modulateurs du système urotensinergétique

  2017cites this paper
• The G Protein-Coupled Receptor UT of the Neuropeptide Urotensin II Displays Structural and Functional Chemokine Features

  2017cites this paper
• Role of urotensin II in advanced glycation end product-induced extracellular matrix synthesis in rat proximal tubular epithelial cells.

  2016cites this paper
• Urolinin: The First Linear Peptidic Urotensin-II Receptor Agonist.

  2016cites this paper
• International Union of Basic and Clinical Pharmacology. XCII. Urotensin II, Urotensin II–Related Peptide, and Their Receptor: From Structure to Function

  2015cites this paper
• Circulating levels of the vasoactive peptide urotensin II in patients with acute coronary syndrome and stable coronary artery disease.

  2014cites this paper
• Coronary slow flow phenomenon associated with high serum levels of soluble CD40 ligand and urotensin II: a multi-marker approach.

  2014cites this paper
• Analysis of genetic variation within urotensin-II system in regulation of blood pressure and renal function

  2013cites this paper
• Emerging drugs for managing kidney disease in patients with diabetes

  2013cites this paper
• Urotensin II and the kidney

  2013cites this paper
• Traditional and Novel Risk Factors in Atherothrombosis

  2012cites this paper
• Urotensin Inhibition with Palosuran Could Be a Promising Alternative in Pulmonary Arterial Hypertension

  2012cites this paper
• A closer look at the role of urotensin II in the metabolic syndrome

  2012cites this paper
• Urotensin II promotes the proliferation of endothelial progenitor cells through p38 and p44/42 MAPK activation.

  2012cites this paper
• Roles of Serotonin in Atherothrombosis and Related Diseases

  2012cites this paper
• Urotensin II inhibits the proliferation but not the differentiation of cardiac side population cells.

  2011cites this paper
• Therapeutic Potential for Protein Kinase C Inhibitor in Vascular Restenosis

  2011cites this paper
• Potential Clinical Implications of the Urotensin II Receptor Antagonists

  2011influential citation
• Effects of exogenous urotensin II on vascular remodelling after balloon injury

  2010cites this paper
• rotein expression of urotensin II , urotensin-related peptide and their eceptor in the lungs of patients with lymphangioleiomyomatosis

  2010cites this paper
• The pro-angiogenic activity of urotensin-II on human vascular endothelial cells involves ERK1/2 and PI3K signaling pathways.

  2010cites this paper
• Expression of urotensin II and its receptor in human lung adenocarcinoma A549 cells and the effect of urotensin II on lung adenocarcinoma growth in vitro and in vivo.

  2010cites this paper
• Urotensin II receptor antagonist attenuates monocrotaline-induced cardiac hypertrophy in rats.

  2010cites this paper
• Urotensin II-induced increase in myocardial distensibility is modulated by angiotensin II and endothelin-1.

  2009cites this paper
• Increased plasma urotensin-II and carotid atherosclerosis are associated with vascular dementia.

  2009cites this paper
• Relation of urotensin II levels to lone atrial fibrillation.

  2009cites this paper
• Human urotensin II promotes hypertension and atherosclerotic cardiovascular diseases.

  2009cites this paper
• Characterization of the insulinostatic effect of urotensin II: a study in the perfused rat pancreas.

  2009cites this paper
• Targeted overexpression of the human urotensin receptor transgene in smooth muscle cells: effect of UT antagonism in ApoE knockout mice fed with Western diet.

  2009cites this paper
• Applications of variable number tandem repeat genotyping in the validation of an animal medical model and gene flow studies in threatened populations of reptiles

  2009cites this paper
• Biological properties and functional determinants of the urotensin II receptor.

  2008cites this paper
• Cardiorenovascular effects of urotensin II and the relevance of the UT receptor.

  2008cites this paper
• Therapeutic targets in hypertension: is there a place for antagonists of the most potent vasoconstrictors?

  2008cites this paper
• Elevated expression of urotensin II and its receptor in diabetic cardiomyopathy.

  2008cites this paper
• Urotensin II: A New Pharmacologic Target in the Treatment of Cardiovascular Disease

  2008cites this paper
• Urotensin II induces phenotypic differentiation, migration, and collagen synthesis of adventitial fibroblasts from rat aorta

  2008cites this paper
• Role of urotensin II in atherosclerotic cardiovascular diseases.

  2008cites this paper
• The role of urotensin II in the metabolic syndrome.

  2008cites this paper
• Chronic urotensin II infusion enhances macrophage foam cell formation and atherosclerosis in apolipoprotein E-knockout mice

  2008cites this paper
• Increased plasma urotensin-II levels are associated with diabetic retinopathy and carotid atherosclerosis in Type 2 diabetes.

  2008cites this paper
• Impact of increased plasma serotonin levels and carotid atherosclerosis on vascular dementia.

  2007cites this paper
• Role of PKC in the novel synergistic action of urotensin II and angiotensin II and in urotensin II-induced vasoconstriction.

  2007cites this paper
• Urotensin-II in the lung: A matter for vascular remodelling and pulmonary hypertension?

  2007cites this paper
• Therapeutic potential of blockade of the Urotensin II system in systemic hypertension

  2007cites this paper
• Proliferation and anti-apoptotic effects of human urotensin II on human endothelial cells.

  2006cites this paper
• Human Urotensin II as a Link between Hypertension and Coronary Artery Disease

  2006cites this paper
• Serotonin acts as an up-regulator of acyl-coenzyme A:cholesterol acyltransferase-1 in human monocyte-macrophages.

  2006cites this paper
• Human Urotensin-II Potentiates the Mitogenic Effect of Mildly Oxidized Low-Density Lipoprotein on Vascular Smooth Muscle Cells: Comparison with Other Vasoactive Agents and Hydrogen Peroxide

  2006cites this paper
• The role of urotensin II in cardiovascular and renal physiology and diseases

  2006cites this paper
• Urotensin-II and cardiovascular diseases

  2006cites this paper
• A new signaling paradigm for serotonin: use of Crk-associated substrate in arterial contraction.

  2006cites this paper
• Alteration of vascular urotensin II receptor in mice with apolipoprotein E gene knockout.

  2006cites this paper
• Urotensin-II blockade with SB-611812 attenuates cardiac dysfunction in a rat model of coronary artery ligation.

  2006cites this paper
• Enhancement of vascular smooth muscle cell migration by urotensin II

  2006cites this paper
• Urotensin II: Its Function in Health and Its Role in Disease

  2005cites this paper
• The protein kinase C inhibitor, bisindolylmaleimide (I), inhibits voltage-dependent K+ channels in coronary arterial smooth muscle cells.

  2005cites this paper
• Staurosporine Inhibits Voltage-Dependent K+ Current Through a PKC-Independent Mechanism in Isolated Coronary Arterial Smooth Muscle Cells

  2005cites this paper
• Human Urotensin II Accelerates Foam Cell Formation in Human Monocyte-Derived Macrophages

  2005cites this paper
• Increased expression of urotensin II and its cognate receptor GPR14 in atherosclerotic lesions of the human aorta.

  2004cites this paper
• The relationship between urotensin II plasma immunoreactivity and left ventricular filling pressures in coronary artery disease.

  2004cites this paper
• Pharmacology of the Urotensin-II Receptor Antagonist ACT-058362: First Demonstration of a Pathophysiological Role of the Urotensin System

  2004cites this paper
• Role of urotensin II in peripheral tissue as an autocrine/paracrine growth factor.

  2004cites this paper
• Elevated plasma human urotensin-II-like immunoreactivity in ischemic cardiomyopathy.

  2004cites this paper
• Pharmacology of the Urotensin-II Receptor Antagonist Palosuran (ACT-058362; 1-[2-(4-Benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea Sulfate Salt): First Demonstration of a Pathophysiological Role of the Urotensin System

  2004cites this paper
• Vasoactive renal factors and the progression of diabetic nephropathy.

  2004cites this paper
• Direct block by bisindolylmaleimide of the voltage-dependent K+ currents of rat mesenteric arterial smooth muscle.

  2004cites this paper
• Urotensin II: the old kid in town.

  2004cites this paper
• Emerging roles of urotensin-II in cardiovascular disease.

  2004cites this paper
• Urotensin II promotes hypertrophy of cardiac myocytes via mitogen-activated protein kinases.

  2004cites this paper
• Role of ERK and Rho kinase pathways in central pressor action of urotensin II

  2004cites this paper
• From 'gills to pills': urotensin-II as a regulator of mammalian cardiorenal function.

  2004cites this paper
• Translational medicine in fish-derived peptides: from fish endocrinology to human physiology and diseases.

  2004cites this paper
• Coagulation factor Xa synergistically interacts with serotonin in inducing vascular smooth muscle cell proliferation.

  2003cites this paper
• The Expression of Urotensin II Receptor (U2R) is Up‐regulated by Interferon‐γ

  2003cites this paper
• Urotensin II-induced activation of extracellular signal-regulated kinase in cultured vascular smooth muscle cells: involvement of cell adhesion-mediated integrin signaling.

  2003cites this paper
• The role of 5-HT on the cardiovascular and renal systems and the clinical potential of 5-HT modulation

  2003cites this paper
• Expression of urotensin II and its receptor in adrenal tumors and stimulation of proliferation of cultured tumor cells by urotensin II.

  2003cites this paper
• Anaemia and risk of chronic vascular disease in chronic renal infection Related review: Anaemia, cardiovascular disease

  2003cites this paper
• Functional and Binding Characterizations of Urotensin II-Related Peptides in Human and Rat Urotensin II-Receptor Assay

  2003cites this paper
• Plasma levels and cardiovascular gene expression of urotensin-II in human heart failure.

  2002cites this paper
• Is urotensin‐II the new endothelin?

  2002cites this paper
• Lysophosphatidylcholine potentiates the mitogenic effect of various vasoactive compounds on rabbit aortic smooth muscle cells.

  2002cites this paper
• Plasma Urotensin in Human Systolic Heart Failure

  2002cites this paper